Gibson Frank C, Genco Caroline A
Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Curr Pharm Des. 2007;13(36):3665-75. doi: 10.2174/138161207783018554.
Toll-like receptors (TLRs) are a group of pathogen-associated molecular pattern receptors, which play an important role in innate immune signaling in response to microbial infection. It has been demonstrated that TLRs are differentially up regulated in response to microbial infection and chronic inflammatory diseases such as atherosclerosis. Furthermore hyperlipidemic mice deficient in TLR2, TLR4, and MyD88 signaling exhibit diminished inflammatory responses and decreased atherosclerosis. Accumulating evidence has implicated specific infectious agents including the periodontal disease pathogen Porphyromonas gingivalis in the progression of atherosclerosis. Evidence in humans suggesting that periodontal infection predisposes to atherosclerosis is derived from studies demonstrating that the periodontal pathogen P. gingivalis resides in the wall of atherosclerotic vessels and seroepidemiological studies demonstrating an association between pathogen-specific IgG antibodies and atherosclerosis. We have established that the inflammatory signaling pathways that P. gingivalis utilizes is dependent on the cell type and this specificity clearly influences innate immune signaling in the context of local and distant chronic inflammation induced by this pathogen. We have demonstrated that P. gingivalis requires TLR2 to induce oral inflammatory bone lose in mice. Furthermore, we have demonstrated that P. gingivalis infection accelerates atherosclerosis in hyperlipidemic mice with an associated increase in expression of TLR2 and TLR4 in atherosclerotic lesions. Our recent work with P. gingivalis has demonstrated the effectiveness of specific intervention strategies (immunization) in the prevention of pathogen-accelerated atherosclerosis. Improved understanding of the mechanisms driving infection, and chronic inflammation during atherosclerosis may ultimately provide new targets for therapy.
Toll样受体(TLRs)是一组病原体相关分子模式受体,在应对微生物感染的固有免疫信号传导中发挥重要作用。已证明,TLRs在应对微生物感染和慢性炎症性疾病(如动脉粥样硬化)时会有不同程度的上调。此外,缺乏TLR2、TLR4和MyD88信号传导的高脂血症小鼠表现出炎症反应减弱和动脉粥样硬化减轻。越来越多的证据表明,包括牙周病病原体牙龈卟啉单胞菌在内的特定感染因子与动脉粥样硬化的进展有关。在人类中,表明牙周感染易患动脉粥样硬化的证据来自多项研究,这些研究表明牙周病原体牙龈卟啉单胞菌存在于动脉粥样硬化血管壁中,血清流行病学研究表明病原体特异性IgG抗体与动脉粥样硬化之间存在关联。我们已经确定,牙龈卟啉单胞菌利用的炎症信号通路取决于细胞类型,这种特异性在由该病原体诱导的局部和远处慢性炎症的背景下,显然会影响固有免疫信号传导。我们已经证明,牙龈卟啉单胞菌在小鼠中诱导口腔炎症性骨质流失需要TLR2。此外,我们已经证明,牙龈卟啉单胞菌感染会加速高脂血症小鼠的动脉粥样硬化,同时动脉粥样硬化病变中TLR2和TLR4的表达会相应增加。我们最近对牙龈卟啉单胞菌的研究表明了特定干预策略(免疫)在预防病原体加速的动脉粥样硬化方面的有效性。更好地理解动脉粥样硬化期间驱动感染和慢性炎症的机制最终可能会提供新的治疗靶点。